Drug-resistance is a growing threat to global efforts in controlling and managing TB infections. Drug-susceptible TB is curable but drug misuse and poor patient compliance leads to multidrug resistance to the first line of TB antibiotics, rifampicin and isoniazid. The second line of treatment is less potent and has severe side effects, takes longer to cure the disease, and has poor success rates (Gandhi et al., 2010). | MDR-TB and XDR-TB surveillance highlights need for rapid detection of drug-resistance in Mycobacterium tuberculosis infections
